It has been shown that the EBV oncoprotein LMP1 was responsible for mediating resistance to the cytostatic effects of TGF-β1 in BL cells (BL41) by elevating levels of cyclin D2 [73]. The gene discussed is TGFB1; the disease is Burkitt lymphoma.